Guiling S. Wang

Key Laboratory Of Cell Biology, Ministry Of Public Health And Key Laboratory Of Medical Cell Biology
Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Correction: Unlocking the adenosine receptor mechanism of the tumour immune microenvironment.

Correction: Unlocking the adenosine receptor mechanism of the tumour immune microenvironment.

Journal: Frontiers in immunology
Published: January 12, 2026

Repurposing niclosamide for COVID-19: Synergistic strategies of nanotechnology and novel materials to enhance antiviral efficacy.

Repurposing niclosamide for COVID-19: Synergistic strategies of nanotechnology and novel materials to enhance antiviral efficacy.

Journal: Microbial pathogenesis
Published: July 08, 2025

Unravelling the influence of structure on the optical properties of a pair of aza-BODIPY isomers and their application in photodynamic therapy.

Unravelling the influence of structure on the optical properties of a pair of aza-BODIPY isomers and their application in photodynamic therapy.

Journal: Journal of materials chemistry. B
Published: January 02, 2025

Unlocking the adenosine receptor mechanism of the tumour immune microenvironment.

Unlocking the adenosine receptor mechanism of the tumour immune microenvironment.

Journal: Frontiers in immunology
Published: May 17, 2024

Mendelian randomisation analysis to explore the association between cathepsins and bipolar disorder.

Mendelian randomisation analysis to explore the association between cathepsins and bipolar disorder.

Journal: BMC psychiatry
Published: April 22, 2024

Targeting glutamine metabolism crosstalk with tumor immune response.

Targeting glutamine metabolism crosstalk with tumor immune response.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: April 05, 2024

YTHDF1 in Tumor Cell Metabolism: An Updated Review.

YTHDF1 in Tumor Cell Metabolism: An Updated Review.

Journal: Molecules (Basel, Switzerland)
Published: November 22, 2023

Aza-BODIPY with two efficacious fragments for NIR light-driven photothermal therapy by triggering cancer cell apoptosis.

Aza-BODIPY with two efficacious fragments for NIR light-driven photothermal therapy by triggering cancer cell apoptosis.

Journal: Journal of materials chemistry. B
Published: November 03, 2023

Oncogenic MORC2 in cancer development and beyond.

Oncogenic MORC2 in cancer development and beyond.

Journal: Genes & diseases
Published: March 06, 2023

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases.

Journal: International journal of molecular sciences
Published: October 24, 2022

Synthesis of aza-BODIPYs with barrier-free rotation of the -tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis.

Synthesis of aza-BODIPYs with barrier-free rotation of the -tBu group at 3-site and enhancement of photothermal therapy by triggering cancer cell apoptosis.

Journal: Journal of materials chemistry. B
Published: October 04, 2022

Attachment of -tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism.

Attachment of -tBu groups to aza-BODIPY core at 3,5-sites with ultra-large Stokes shift to enhance photothermal therapy through apoptosis mechanism.

Journal: Materials today. Bio
Published: August 10, 2022
Showing 1-12 of 22

Last Updated: 09/26/2026